+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07069400

An International Observational Study of Adults With Acute Infection

Led by University of Minnesota · Updated on 2026-04-02

1500

Participants Needed

47

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting an international observational study to better understand acute infections in adults who are hospitalized. This study focuses on collecting data and biospecimens to characterize various infectious diseases, including respiratory infections, infections outside the respiratory tract, established infectious diseases, and newly emerging infections. The aim is to gather information that will help identify risk factors, clinical features, and management strategies, as well as to aid in designing future clinical trials. Participants include adults admitted to the hospital with suspected or confirmed acute infections. There is no intervention or treatment being tested, as this is an observational study. The research involves monitoring patients during their hospital stay to collect vital data and samples related to their infection. Participants will be observed over time, with researchers assessing outcomes such as mortality by day 28, time to recovery, clinical improvement by day 7, organ support-free days, and organ failure scores. Data collection includes clinical assessments and biospecimen sampling to better understand infection progression and patient recovery. The study begins in August 2025 and continues through June 2027, allowing for extensive data gathering and analysis.

CONDITIONS

Brief Title

An International Observational Study of Adults With Acute Infection

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Hospital admission or emergency department visit with anticipated hospital admission for suspected or confirmed acute infection
  • Symptoms of infection started within the past 30 days
  • Ability to provide informed consent or have a surrogate decision maker consent if unable
Not Eligible

You will not qualify if you...

  • Currently imprisoned (excluding quarantine for infectious disease)
  • Receiving comfort care focused on end-of-life symptom management instead of life prolongation
  • Expected inability or unwillingness to participate in study procedures
  • Investigator determines participation is not in the patient's best interest

Research Team

R

Rebecca Schoenecker

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here